On 2025-05-06, Lyra Therapeutics, Inc. (LYRA) announced earnings per share of $-6.00 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-7.50.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-5.79 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-7.50 | $-6.00 |
| 2025-03-13 | 2024-12-31 | $-6.00 | $-8.00 |
| 2024-11-12 | 2024-09-30 | $-11.50 | $-9.00 |
| 2024-08-14 | 2024-06-30 | $-17.00 | $-14.50 |
| 2024-04-30 | 2024-03-31 | $-13.00 | $-17.50 |
| 2024-03-21 | 2023-12-31 | $-16.50 | $-11.00 |
| 2023-11-07 | 2023-09-30 | $-16.50 | $-13.50 |
| 2023-08-08 | 2023-06-30 | $-22.00 | $-16.50 |
| 2023-05-12 | 2023-03-31 | $-18.00 | $-22.00 |
| 2023-03-29 | 2022-12-31 | $-21.00 | $-18.00 |
| 2022-11-08 | 2022-09-30 | $-21.00 | $-20.00 |
| 2022-08-09 | 2022-06-30 | $-17.00 | $-21.50 |
| 2022-05-10 | 2022-03-31 | $-46.00 | $-27.00 |
| 2022-03-09 | 2021-12-31 | $-41.00 | $-52.50 |
| 2021-11-09 | 2021-09-30 | $-39.00 | $-42.50 |
| 2021-08-09 | 2021-06-30 | $-30.50 | $-42.50 |
| 2021-05-11 | 2021-03-31 | $-24.00 | $-30.00 |
| 2021-03-09 | 2020-12-31 | $-30.50 | $-23.00 |
| 2020-11-10 | 2020-09-30 | $-24.00 | $-24.50 |
| 2020-08-05 | 2020-06-30 | $-18.50 | $-28.00 |
| 2020-05-28 | 2020-03-31 | -- | $-935.00 |